Thursday, September 13, 2012
Saturday, May 5, 2012
Thursday, February 9, 2012
Wednesday, December 28, 2011
There were many important arguments presented for or against screening for Alzheimer’s. You can listen to the podcast here. In particular, since there is no treatment available, it seems pointless to screen for Alzheimer’s. However, if you want to participate in clinical trials that might someday stop or reverse Alzheimer's disease, it's important to screen for it. Here is the map of current ongoing clinical trials on Alzheimer's disease.
Tuesday, August 9, 2011
Monday, May 2, 2011
From FDA news release: FDA approves new treatment for Type 2 diabetes. The clinical trial mentioned in this news release seems to be this one: Safety and Efficacy of BI 1356 as Monotherapy or in Combination in Type 2 DM.
According to MedlinePlus, Type 2 Diabetes is a chronic (lifelong) disease marked by high levels of sugar (glucose) in the blood. The chronic (lifelong) part makes it very attractive target for Pharma. There are currently more than 60 clinical trials for Diabetes Mellitus, Type 2 including new clinical trials that use linagliptin, and other dipeptidyl peptidase 4 (DPP4) inhibitors.